<?xml version="1.0" encoding="UTF-8"?>
<p id="para0056">As the report goes, certain drugs are known to effectively treat patients with COVID-19. Nevertheless, the lack of clinical data may render the clinical prognosis difficult to predict. In addition to the judicious design of novel therapeutics that target viral replication or immunopathology, currently, rapid screening of therapeutic agents to repurpose FDA-approved and well-characterized agents might be a more workable method. Considering the severity of the recent zoonotic coronavirus outbreaks, therapeutic drugs for pancoronavirus should be carried out to cope with future outbreaks.</p>
